NCT06410118

The DreamChanger Intervention in Combination With Imagery Rehearsal Therapy for Children's Nightmares

Efficacy of the DreamChanger Intervention in Combination With Imagery Rehearsal Therapy to Reduce Nightmares in Children
Tel Aviv University·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Nightmare
Drug/Device/Intervention
DreamChanger+IRT
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Tel Aviv University
Location
Tel Aviv, Israel
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Dec 01, 2025
Enrollment
120 participants
Primary outcome

Nightmare frequency and severity

Summary

This clinical trial will test the efficacy of parent-delivered DreamChanger Intervention in
 combination with Imagery Rehearsal Therapy (IRT) for reducing the frequency and severity of
 nightmares in children aged 3-10. Children will be randoimized to either the combined
 intervention or to a waitlist control group.The intervention will include providing children
 with the DreamChanger remote, and providing parents with instructional videos, explaining how
 to use the device along with the IRT strategy to address nightmares.
 
 At baseline, mid-treatment, and post-treatment, parents in both groups will complete
 questionnaires asking about the child's nightmares, sleep, externalizing and internalizing
 symptoms, PTSD symptoms, demographic characteristics, and parent sleep and distress. Parents
 in the intervention group will also be asked to complete questionnaires regarding their
 compliance and satisfaction with the intervention, as well as a 3-month follow-up assessment.

ICD-10 classifications
NightmaresSleep terrors [night terrors]Personal frightening experience in childhood
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06410118
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06410118 through Pure Global AI's free database. This phase not specified trial is sponsored by Tel Aviv University and is currently Not yet recruiting. The study focuses on Nightmare. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.